Stateside's Canadian Microcap Board Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Stateside's Canadian Microcap Board

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: statesidereport	12/29/2015 6:47:48 PM
	Read Replies (1) of 1728

Looks like BCT has bottomed but trailing TLT significantly. Own both for cancer treatments. BCT, in my opinion, has the better medical team and possible cure but they are inept at marketing so TLT share price and market cap has far exceeded BCT now where at one point this year BCT's share price was higher. BCT management has no idea how to promote. It will take the release of the Phase II results to garner any attention. No one buying BCT in large volumes in advance unlike TLT who has much more promo. stateside

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next